Biorestorative TherapiesBRTX
13F holders, Q2 2024 (June 30)13holders
3new positions
3sold out
$2.03avg. 13F price*
At the end of Q2 2024, 13 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, unchanged from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were StoneX Group Inc. ($116K), Geode Capital Management, LLC ($106K) and Wealth Alliance, LLC ($81K).
- Company
- Biorestorative Therapies Inc.
- CUSIP
- 090655606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $35K |
| Exits | 3 | $292K |
All 13F filers, Q1 2024 → Q2 2024: 85,248 shares bought and 214,088 shares sold, net −128,840 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| StoneX Group Inc. | 0.01% | Add +63.3% | 56,921 | $116K |
| Geode Capital Management, LLC | 0.00% | Add +29.4% | 52,337 | $106K |
| Wealth Alliance, LLC | 0.01% | No change | 40,000 | $81K |
| UBS Group AG | 0.00% | Add +3211.1% | 27,813 | $56K |
| Vanguard Group Inc. | 0.00% | No change | 20,472 | $42K |
| State Street Corp. | 0.00% | No change | 20,459 | $42K |
| US Financial Advisors, LLC | 0.01% | New | 17,142 | $35K |
| Morgan Stanley | 0.00% | Add +50.0% | 15,000 | $30K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +80.2% | 4,795 | $10K |
| Wells Fargo & Company | 0.00% | Reduce -34.8% | 965 | $2K |
| Osaic Holdings, Inc. | 0.00% | Reduce -91.2% | 193 | $391 |
| Bank of America Corp. | 0.00% | New | 47 | $95 |
| Janiczek Wealth Management, LLC | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.